Polymorphisms of the CLCN7 gene are associated with BMD in women

Ulrika Pettersson, Omar Al Bagha, Max Mirolo, Anna Taranta, Annalisa Frattini, Fiona E.A. McGuigan, Paolo Vezzoni, Anna Teti, Wim Van Hul, David M. Reid, Anna Villa, Stuart H. Ralston

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Here we show that a common polymorphism causing a valine to methionine amino acid substitution at codon 418 (V418M) in the CLCN7 gene is associated with femoral neck BMD in women. Our study adds to accumulating evidence that shows that common allelic variants in monogenic bone disease genes often contribute to BMD regulation in normal subjects. Introduction: The CLCN7 gene is a strong candidate for regulation of BMD, because mutations in CLCN7 cause some forms of osteopetrosis, a disease characterized by impaired osteoclast function and increased BMD. In this study, we sought to determine whether common allelic variation within CLCN7 was associated with BMD in the normal population. Materials and Methods: We conducted mutation screening of the exons and intron-exon boundaries in CLCN7 by DNA sequencing in 50 normal subjects. We conducted an association study between common polymorphisms in CLCN7 and haplotypes defined by these polymorphisms and BMD values at the lumbar spine and femoral neck in a population-based cohort study of 1077 Scottish women 45-55 years of age. Results: We identified 24 polymorphisms, but most were rare and only 4 had allele frequencies of >5%. These were a conservative single nucleotide polymorphism (SNP) in exon 1 (rs3751884), a 50-bp tandem repeat polymorphism within intron 8, and two SNPs within exon 15 (rs12926089 and rs12926669), of which one (rs12926669) predicts an amino acid change from valine to methionine at codon 418 (V418M). The exon 15 SNPs were in strong linkage disequilibrium and were both associated with femoral neck BMD (p = 0.001-0.003). None of the other polymorphisms were associated with BMD, and long-range haplotypes showed a much weaker association with BMD than the exon 15 SNPs. The V418M polymorphism was an independent predictor of femoral neck BMD on multiple regression analysis accounting for 1% of the variance in BMD at this site. Conclusions: Our study indicates that the V418M polymorphism of CLCN7 contributes to the genetic regulation of femoral neck BMD in women and adds to accumulating evidence that indicates that subtle polymorphic variation in genes that cause monogenic bone diseases also contribute to regulation of BMD in normal subjects.

Original languageEnglish
Pages (from-to)1960-1967
Number of pages8
JournalJournal of Bone and Mineral Research
Volume20
Issue number11
DOIs
Publication statusPublished - Nov 2005
Externally publishedYes

    Fingerprint

Keywords

  • BMD
  • CLCN7
  • Genetic
  • Polymorphism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Pettersson, U., Al Bagha, O., Mirolo, M., Taranta, A., Frattini, A., McGuigan, F. E. A., Vezzoni, P., Teti, A., Van Hul, W., Reid, D. M., Villa, A., & Ralston, S. H. (2005). Polymorphisms of the CLCN7 gene are associated with BMD in women. Journal of Bone and Mineral Research, 20(11), 1960-1967. https://doi.org/10.1359/JBMR.050717